Skip to main content
Sherilyn Tuazon, MD, Oncology, Seattle, WA, Fred Hutchinson Cancer Center

SherilynAlvaranTuazonMDMS

Oncology Seattle, WA

Hematologic Oncology

Assistant Professor/Assistant Member, University of Washington/Fred Hutchinson Cancer Research Center

Dr. Tuazon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tuazon's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 2015
  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2009 - 2012
  • University of Santo Tomas
    University of Santo TomasClass of 2006

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2016 - 2024
  • VA State Medical License
    VA State Medical License 2014 - 2016
  • PA State Medical License
    PA State Medical License 2012 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Magna cum laude University of Santo Tomas Faculty of Medicine and Surgery, 2006

Publications & Presentations

PubMed

Abstracts/Posters

  • Efficacy and Safety of Fully Human Bcma CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase Bcma Surface Expression in Patients with Relapsed or Re...
    Sherilyn A. Tuazon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Prolonged Lenalidomide Therapy in Multiple Myeloma Patients Does Not Impact Autologous PBSC Mobilization: A Single Center Retrospective Analysis 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • The Alpha Emitter Astatine-211 Targeted to CD38 Can Eradicate Multiple Myeloma in Minimal Residual Disease Models 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

Other Languages

  • Filipino

Hospital Affiliations